We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
-8.2%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$462M
AUM Growth
-$51.6M
Cap. Flow
-$441K
Cap. Flow %
-0.1%
Top 10 Hldgs %
15.6%
Holding
395
New
18
Increased
8
Reduced
14
Closed
13

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.31M
2
ABBV icon
AbbVie
ABBV
+$1.95M
3
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$1.27M
4
GERN icon
Geron
GERN
+$1.18M
5
KHC icon
Kraft Heinz
KHC
+$1.16M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.93M
2
AMAG
AMAG Pharmaceuticals
AMAG
+$1.86M
3
AEC
ASSOCIATED ESTATES REALTY CORP
AEC
+$1.72M
4
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$1.3M
5
PLL
PALL CORP
PLL
+$1.25M

Sector Composition

Rank Sector Weight
1 Technology 16.61%
2 Financials 14.94%
3 Healthcare 14.92%
4 Industrials 11.55%
5 Consumer Staples 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$21M 4.54%
762,000
– –
JPM icon
2
JPMorgan Chase
JPM
$935B
$8.23M 1.78%
135,000
– –
MSFT icon
3
Microsoft
MSFT
$3.45T
$8.19M 1.77%
185,000
– –
XOM icon
4
ExxonMobil
XOM
$644B
$5.21M 1.13%
70,000
– –
WFC icon
5
Wells Fargo
WFC
$261B
$5.13M 1.11%
100,000
– –
DIS icon
6
Walt Disney
DIS
$167B
$5.11M 1.11%
50,000
– –
PG icon
7
Procter & Gamble
PG
$336B
$5.04M 1.09%
70,000
– –
ALK icon
8
Alaska Air
ALK
$5.29B
$4.77M 1.03%
60,000
– –
PM icon
9
Philip Morris
PM
$297B
$4.76M 1.03%
60,000
– –
JNJ icon
10
Johnson & Johnson
JNJ
$618B
$4.67M 1.01%
50,000
-20,000
-29% -$1.93M
MRK icon
11
Merck
MRK
$322B
$4.61M 1%
97,728
– –
MO icon
12
Altria Group
MO
$114B
$4.35M 0.94%
80,000
– –
LOW icon
13
Lowe's Companies
LOW
$117B
$4.13M 0.89%
60,000
– –
AMZN icon
14
Amazon
AMZN
$2.92T
$4.09M 0.89%
160,000
-40,000
-20% -$1.01M
CSCO icon
15
Cisco
CSCO
$457B
$3.94M 0.85%
150,000
– –
GILD icon
16
Gilead Sciences
GILD
$162B
$3.93M 0.85%
40,000
– –
AXP icon
17
American Express
AXP
$227B
$3.71M 0.8%
50,000
– –
PFE icon
18
Pfizer
PFE
$143B
$3.64M 0.79%
122,218
-36,890
-23% -$1.18M
ORCL icon
19
Oracle
ORCL
$374B
$3.61M 0.78%
100,000
– –
ALKS icon
20
Alkermes
ALKS
$8.22B
$3.52M 0.76%
60,000
– –
MCD icon
21
McDonald's
MCD
$192B
$3.46M 0.75%
35,093
– –
INTC icon
22
Intel
INTC
$455B
$3.31M 0.72%
110,000
– –
USB icon
23
US Bancorp
USB
$98.2B
$3.28M 0.71%
80,000
– –
CORE
24
DELISTED
Core Mark Holding Co., Inc.
CORE
$3.27M 0.71%
100,000
– –
TRV icon
25
Travelers Companies
TRV
$78.1B
$3.23M 0.7%
32,443
– –
1
2 3 4 5

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q3 2015 Portfolio in Review

As of Q3 2015, NJ State Employees Deferred Compensation Plan held 395 positions worth $462M, down 10% from $514M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

NJ State Employees Deferred Compensation Plan's Q3 2015 filing shows 18 new, 8 increased, 14 reduced and 13 closed positions. Its largest new stake was Biogen: 7,000 shares worth $2.04M. The largest sale was Johnson & Johnson, an estimated $1.93M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • NJ State Employees Deferred Compensation Plan's largest Q3 2015 buy was Biogen: 7,000 shares worth $2.04M.
  • NJ State Employees Deferred Compensation Plan added most to AbbVie in Q3 2015, an estimated $1.95M increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q3 2015 reduction was Johnson & Johnson, cutting an estimated $1.93M.
  • NJ State Employees Deferred Compensation Plan fully exited ASSOCIATED ESTATES REALTY CORP in Q3 2015, selling an estimated $1.72M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 16% of its $462M portfolio in Q3 2015.
  • NJ State Employees Deferred Compensation Plan opened 18 new positions and closed 13 in Q3 2015.
  • NJ State Employees Deferred Compensation Plan's portfolio value fell 10% quarter-over-quarter to $462M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2015, filed 2 Nov 2015.